October 18, 2018
October 17, 2018
The Institute for Clinical and Economic Review says new medicine for uncontrolled asthma isn’t worth its cost. But its analysis…
October 4, 2018
It might just be the worst disease you have never heard of.
September 12, 2018
Since Congress created an approval pathway for follow-on biological drugs in 2009, nearly a dozen biosimilars have been approved by the FDA. Many more are in the pipeline.
August 30, 2018
Patient access developments didn’t stop for summer. As we head into fall, here are 10 quotes from the news items – and new materials – that kept the health policy conversation lively during summer 2018.
June 25, 2018
Not everyone can afford the medication they need. To make drugs more accessible, manufacturers sometimes provide co-pay coupons to help patients cover their out-of-pocket pharmacy expenses.
June 19, 2018
Treating asthma is not a one-size-fits-all exercise, as patients and clinicians well know. So why do some health plan policies suggest otherwise? The question drives a new policy brief from the Institute for Patient Access.
June 19, 2018
The more than 25 million Americans with asthma experience wheezing, coughing, chest tightness and shortness of breath. Their condition can…
June 4, 2018
As noted in ICER’s scoping document, uncontrolled asthma is a substantial problem that, according to the Centers for Disease Control and Prevention, afflicts 38.4 percent of children with asthma and 50 percent of adults with asthma. It is not clear from the scoping document, however, that ICER will adequately incorporate into its analysis several key issues associated with uncontrolled asthma.
April 26, 2018
Many Americans felt like they knew former first lady Barbara Bush, whose death the country mourned this month. But how much do we as a nation know about the disease that killed her?
